AN INVESTIGATION INTO THE THEORY AND PRACTICE OF HYDRAULIC MORTAR, AS MADE ON THE NEW WORKS OF THE LONDON DOCK COMPANY, 1856-57. (INCLUDING APPENDIX). [PDF]
Gordon G. Robertson
openalex +1 more source
DISCUSSION. KING GEORGE DOCK, HULL : MAJOR DEVELOPMENTS, 1959-1963. [PDF]
D G MCGAREY+9 more
openalex +1 more source
Improved protein–ligand docking using GOLD
M. Verdonk+4 more
semanticscholar +1 more source
A novel artemisinin derivative dimer has been synthesized, and its significant potential as an anti‐cancer agent. The study indicated that ZQJ29 effectively inhibited the proliferation of pancreatic cancer cells in vitro and in vivo. Additionally, these investigations have unveiled ZQJ29 as a new potent PARP1 inhibitor, with the capability to induce ...
Jianping Chen+9 more
wiley +1 more source
Unveiling Isorhapontigenin's therapeutic potential in lung cancer via integrated network pharmacology, molecular docking, and experimental validation. [PDF]
Wu Z+9 more
europepmc +1 more source
Through a comprehensive multi‐omics analysis, this study identifies a marked reduction in Nephronectin (NPNT) expression within fibrotic lung tissue. This reduction impairs the binding capability to the ITGA3 receptor, consequently causing YAP1 to persist in the cytoplasm, where it undergoes degradation.
Jiayu Guo+20 more
wiley +1 more source
Molecular Docking and Molecular Dynamics Study of Propolis Compounds of Sulabiroin-A, Sulabiroin-B, and Broussoflavonol F Toward Tuberculosis 3PTY Target Protein. [PDF]
Fatriansyah JF+5 more
europepmc +1 more source
Activation of Kir4.1 Channels by 2‐D08 Promotes Myelin Repair in Multiple Sclerosis
Multiple sclerosis causes myelin loss and neurological dysfunction. This study shows that 2‐D08, a small molecule targeting Kir4.1 channels, promotes OPCs differentiation via FYN tyrosine kinase phosphorylation and the FYN/MYRF pathway. It significantly improves myelin repair and motor deficits in EAE mice and marmosets, highlighting its potential as a
Mingdong Liu+17 more
wiley +1 more source
High-Risk Neuroblastoma Stage 4 (NBS4): Developing a Medicinal Chemistry Multi-Target Drug Approach. [PDF]
Gerges A, Canning U.
europepmc +1 more source